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Abstract
Purpose Recent epidemiologic studies indicate elevated
risks for some lymphohematopoietic malignancies (LHM)
related to formaldehyde exposure. We performed a sys-
tematic review of literature to assess the strength and
consistency of associations.
Methods We summarized published literature in the
PubMed database of the National Library of Medicine
during 1966–2012. Literature was categorized according to
study design and population: industrial cohort studies,
professional cohort studies, and population-based case–
control studies.
Results Findings from occupational cohort and popula-
tion-based case–control studies were very inconsistent for
LHM, including myeloid leukemia. Apart from some iso-
lated exceptions, relative risks were close to the null, and
there was little evidence for dose–response relations for
any of the LHM.
Conclusions At present, there is no consistent or strong
epidemiologic evidence that formaldehyde is causally rela-
ted to any of the LHM. The absence of established
toxicological mechanisms further weakens any arguments for
causation. To be informative, future epidemiologic research
should improve on formaldehyde exposure assessment and
apply modern diagnostic schemes for specific LHM.
Keywords Formaldehyde  Leukemia  Lymphoma 
Lymphohematopoietic malignancies  Epidemiologic
review  Causation
Introduction
Formaldehyde (CH2O) is a simple one-carbon molecule,
found in most human and other living cells as a normal
product of the metabolism of serine, glycine, methionine,
and choline, and is generated in the demethylation of N-, O-,
and S-methyl compounds. It is also an essential intermediate
in the biosynthesis of purines, thymidine, and various amino
acids [1]. Consequently, formaldehyde is present in virtually
all cells in the body at varying concentrations.
Formaldehyde is also produced commercially and is
valuable as a biocide, preservative, and basic chemical in the
manufacture of common materials such as plastics, building
materials, glues and fabrics, and many household and con-
sumer products, including medicines, health, and beauty aids.
Formaldehyde is also a product of organic matter combustion.
Common exposure sources include some laboratories,
indoor air (e.g., carpets), vehicle emissions, cigarette smoke,
and workplaces manufacturing or using resins, various wood
products (e.g., particle board), adhesives, textiles, and
numerous other consumer products [2]. High concentrations
of formaldehyde were found inside some of the temporary
housing units built for victims of hurricane Katrina in the US
in 2008, which raised the public awareness of the chemical
and its potential acute health effects [3, 4].
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Inhalation is the predominant route of exposure to exog-
enous formaldehyde. Following inhalation, formaldehyde
rapidly reaches cells in the upper respiratory tract and reacts
virtually instantaneously with primary and secondary
amines, thiols, hydroxyls, and amides [5]. Formaldehyde is
swiftly metabolized by erythrocytes [6–9]. Formaldehyde
forms adducts with DNA and proteins and also produces
DNA cross-links [10].
The most common acute health effects of exposure to
formaldehyde include eye and upper respiratory tract irri-
tation. Reversible declines in lung function have also been
observed, although the evidence that it causes asthma and
other chronic respiratory diseases is inconsistent [11]. There
is inadequate evidence to assess other potential adverse
effects of formaldehyde in humans, such as immunotoxic-
ity, neurotoxicity, and reproductive and developmental
toxicity [12, 13].
Carcinogenicity of formaldehyde
Concerns about the carcinogenicity of formaldehyde were
prompted in the early 1980s by the induction of nasal
tumors in rats exposed at high concentrations [14–17]. As a
consequence, the focus of early epidemiologic studies was
on nasal cancer, based on the understanding that formal-
dehyde is rapidly metabolized at the site of contact (i.e.,
nasal passages and cavity) [18–20]. Consequently, associ-
ations between formaldehyde exposure and other malig-
nancies in humans were reported, including nasopharyngeal
carcinoma (NPC), lung cancer, lymphohematopoietic
malignancies (LHM), mainly leukemias, and other cancers
such as brain, colon, and prostate [21, 22]. Epidemiologic
studies on formaldehyde exposure and LHM risk are
reviewed in detail below.
In 2006, the International Agency for Research on
Cancer (IARC) conducted a comprehensive review of the
literature and classified formaldehyde as a known (i.e.,
Group 1) human carcinogen, based on sufficient evidence
for NPC. The evidence for leukemia was considered sug-
gestive [23]. In 2009, IARC conducted an abbreviated
updated review of all Group 1 chemicals, including form-
aldehyde [24], in which the epidemiologic evidence for
leukemia—specifically myeloid leukemias—was classified
as sufficient. The US National Toxicology Program simi-
larly classified formaldehyde as a known human carcino-
gen [25]. The US Environmental Protection Agency (EPA),
in its draft Integrated Risk Information System (IRIS)
report on formaldehyde, concluded that existing epidemi-
ologic evidence supported a causal association with LHM
as a group and specifically for myeloid leukemia [26]. A
special committee of the US National Research Council of
the National Academies critically reviewed the EPA draft
IRIS report and found the causal conclusions for LHM to
be inadequately supported [27].
We undertook a critical, systematic, and comprehensive
review and synthesis of the epidemiologic literature on
formaldehyde and risks of the LHM. Our review is more
thorough than that produced by the National Research
Council [27], which focused on literature summarized in
the EPA draft IRIS document. Our objectives were to
characterize the overall strength and consistency of the
evidence to guide causal interpretations and to recommend
research improvements that would extend knowledge on
this important public health and scientific issue.
Methods
Our methods were consistent with those used by IARC [28]
and others [29–31]. Briefly, we identified published, peer-
reviewed epidemiologic studies specifically addressing
formaldehyde exposure and risk of the LHM. Searches were
conducted in PubMed, the US National Library of Medi-
cine’s primary research tool that indexes most of the world’s
health and medical peer-reviewed journals since at least
1966. All years indexed were searched to identify these
studies using the following key words in various combina-
tions: cancer, leukemia, non-Hodgkin’s lymphoma, lym-
phoma, lymphocytic, Hodgkin’s lymphoma, hematopoietic,
multiple myeloma, hematological neoplasm, formaldehyde,
embalmer, garment, laboratory workers, epidemiology,
case–control, cohort, case-referent, occupational, chemical,
exposure, risk, review, meta-analysis, and commentary. We
identified a total of 1,441 potentially relevant articles from
the literature searches. Of these articles, 126 were retained as
relevant to formaldehyde exposures and LHM. Articles were
excluded if they (1) were not epidemiological studies, (2) did
not focus on formaldehyde, (3) focused on outcomes other
than cancer, or (4) did not present results for specifically for
LHM. Additionally, references cited in other publications,
including reviews, were checked to ensure the thoroughness
of the literature review. We did not attempt to identify
unpublished reports. The final review included a total of 37
articles—22 cohort studies and 17 case–control studies.
We comprehensively reviewed the identified literature,
including studies of occupational groups and population-
based case–control studies of specific LHM that presented
results for formaldehyde-related exposures. Most emphasis
was placed on findings from occupational cohort studies,
which, because of the greater potential for exposure to
substantial concentrations of formaldehyde, provide the
best evidence for possible associations. We limited the
review to the most recent updates of occupational studies,
although we include findings from earlier reports where
results have changed materially with successive updates.
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Defining the outcome of interest is an important aspect
of the design of epidemiologic studies, and the LHM are
particularly challenging in this regard. Much of the infor-
mation about LHM and formaldehyde exposure derives
from mortality data in occupational cohort studies that
spanned several LHM classification schemes. The princi-
ples of the nosological classification of this group of neo-
plasms have changed during the past 40 years, following
the increasing understanding of the pathological and clin-
ical characteristics of the different diseases. The most
substantial changes in the International Classification of
Diseases (ICD) have occurred for the non-Hodgkin lym-
phomas (NHL). Until the 9th Revision of the International
Classification of Diseases (ICD), NHL was classified under
two rubrics: ‘‘lymphosarcoma and reticulosarcoma’’ and
‘‘other neoplasms of the lymphoid tissue’’ (Hodgkin lym-
phoma had a separate code) [32]. In ICD-10, which follows
a new WHO classification, chronic lymphocytic leukemia
(CLL), the most common type of leukemia among the
elderly, is classified as a form of NHL, and other changes
were made to the classification of NHL. The InterLymph
Consortium of lymphoma epidemiology has made an effort
to adapt the last two versions of the WHO classification to
epidemiologic studies, following a hierarchical approach
[33, 34]. Unfortunately, the majority of epidemiologic
studies, in particular occupational cohort studies, which
based outcomes on death certificates, do not follow the
WHO classifications (or its InterLymph adaptation).
We present and discuss findings for specific LHM to the
extent allowed by published data. We do not discuss results
for all LHM combined because diseases in this group are
clinically and pathologically heterogeneous, and thus
probably etiologically distinctive.
We did not perform meta-analyses because our evalua-
tion of the individual studies determined that the literature is
too heterogeneous, that is, inconsistent, with respect to
disease classification and exposure assessment, and there-
fore, quantitative risks are not appropriately combined.
Moreover, the number of independent studies with com-
parable exposure circumstances (i.e., the same industry or
occupation) and similar exposure assessments was too small
to justify meta-analyses of these subsets of results. We were
especially concerned about combining studies of different
groups of workers with poorly characterized circumstances
of exposure to formaldehyde. Several previous meta-anal-
yses [35–38] have been performed, yielding variable con-
clusions, which may result from different methods and the
underlying heterogeneity of exposure and health outcome
data specificity and validity among published studies. In our
opinion, the apparent gain in precision from a meta-analysis
would be offset by problems in the interpretation of the
summary results. We do, however, provide Forest plots of
overall study findings as Figs. 1, 2, 3, 4, and 5.
Epidemiologic literature
Associations between formaldehyde exposure and the
LHM have been investigated among anatomists, patholo-
gists, embalmers, and industrial workers involved in the
manufacture and use of formaldehyde and formaldehyde-
containing products, such as resins, adhesives, wood
products, fabrics, and garments. Formaldehyde has also
been examined as a risk factor in numerous studies con-
ducted in the general population, including population-
based case–control studies and analyses correlating occu-
pations with LHM incidence and mortality. Accordingly,
we present summaries of literature in tabular form sepa-
rately for the following categories: cohort studies of
industrial workers, cohort studies of professional workers,
and population-based cohort and case–control studies.
Among all available literature, we regard two large
occupational cohort studies as most informative because of
the cohort design, greatest likelihood of exposure, quanti-
fication of exposure, and minimized bias and confounding.
These are mortality studies of (1) a cohort of employees of
ten US factories that produced or used formaldehyde,
conducted by the US National Cancer Institute (henceforth
termed the ‘‘NCI producers study’’) [39]1 and (2) a cohort
of employees of six UK factories engaged in the production
of resins, adhesives, and formalin (henceforth termed the
‘‘UK producers study’’) [48].2
A second group of occupational studies that we regard
as less informative includes a cohort of US garment
workers [51–53]3 and a case–control analysis of deaths
among US embalmers and funeral directors [54] that was
based on a series of earlier proportionate mortality studies
[21, 55, 56]. The study base in which the nested case–
control study of LHM in the US embalmers and funeral
directors study was conducted was poorly defined [54], and
the formaldehyde exposure assessment in the garment
workers study [53] was less specific and detailed than in
the two ‘‘producers’’ cohort studies.
The remaining occupational studies reviewed were those
conducted among cohorts of undertakers [57], pathologists
[58], anatomists [59, 60], wood industry workers [61–63],
and general chemical industry workers [20, 64–67]. In
these studies, formaldehyde exposure was less certain than
in aforementioned occupational cohort studies and, in
many cases, was inferred from job title or work area.
The other major categories of epidemiologic studies
reviewed were community-based cohort and case–control
1 Previous publications of the NCI producers study include [40–47].
2 Previous publications of the UK producers study include [49, 50].
3 Previous publications of the US garment workers include [51, 52].
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Fig. 1 Forest plot of formaldehyde exposure and leukemias
Fig. 2 Forest plot of formaldehyde exposure and myeloid leukemia
Fig. 3 Forest plot of formaldehyde exposure and chronic lymphocytic leukemia
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studies and general population surveys, which also provide
limited information on formaldehyde exposure and LHM
risks. Exposure assessment in these studies was generally
based on crude exposure metrics, such as ‘‘low’’ versus
‘‘high’’ exposure probability combinations of heterogeneous
job titles. Details of study design and exposure assessment
for the studies reviewed are summarized in Table 1.
Results
Summary of leukemia findings
The findings for the occupational cohort studies with leu-
kemia outcomes are summarized in Table 2. The two most
influential studies are considered first. Based on compari-
sons with national rates, no excesses for all leukemia
(standardized mortality ratio (SMR) 1.02, 95 % confidence
interval (CI) 0.85–1.22) or myeloid leukemia (SMR 0.90,
95 % CI 0.67–1.21) were found in the most recent follow-
up of the NCI producers’ study. Among the formaldehyde-
exposed portion of the cohort, there was a weak trend of
relative risk (RR) with peak exposure, for both all leuke-
mias and myeloid leukemia, largely influenced by elevated
RRs of 1.78 (95 % CI 0.87–3.64) for myeloid leukemias
and 1.42 (0.92–2.18) for ‘‘other’’ (non-myeloid) leukemias
in the highest peak exposure category. However, most of
the trends and individual RR estimates were not remark-
able or precise. The association for peak exposure and
myeloid leukemia was considerably attenuated from the
previous follow-up of the cohort, RR 2.79 (95 % CI
1.08–7.21, 14 cases, p-trend 0.02) at the highest peak cat-
egory. Beane Freeman [39] corrected the results published
in Hauptmann [47] that inadvertently omitted 1,006 deaths,
Fig. 4 Forest plot of formaldehyde exposure and lymphomas
Fig. 5 Forest plot of formaldehyde exposure and non-Hodgkin lymphoma
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including 22 LHM deaths. No clear associations with
average or cumulative exposure were found in the cor-
rected data for any of the leukemias. Null findings were
reported for lymphatic leukemia and ‘‘other and unspeci-
fied leukemia’’ [39].
Leukemia mortality was not elevated overall (SMR
0.91, 95 % CI 0.62–1.29) or in the most highly exposed
(i.e., jobs with [2 ppm formaldehyde) segment (SMR
0.71, 95 % CI 0.31–1.39) of the UK formaldehyde pro-
ducers study [48]. No separate results for myeloid leuke-
mias were presented.
Among other occupational studies, the nested case–
control analysis of US embalmers reported odds ratios for
myeloid leukemias and for acute myeloid leukemias in the
range of 2.0–3.2 for number of embalmings, and for
cumulative and peak formaldehyde exposure categories,
relative to the referent group that performed \500 career
embalmings. However, the underlying sample of death
certificates evaluated in this analysis demonstrated no
excess of myeloid leukemias: the 29 myeloid leukemias
reported in this study generated a proportionate mortality
ratio (PMR) of 1.08 (95 % CI 0.70–1.56), and the subset of
20 acute myeloid leukemias generated a PMR of 1.16
(0.71–1.79) [68]. Moreover, there was little evidence of
increasing exposure–response trends in the non-reference
exposure categories [54]. In the study of US garment
workers, the SMR for leukemia deaths was 1.09 (95 % CI
0.7–1.62), based on 24 total leukemia deaths. For the 15
observed myeloid leukemias, the SMR was 1.44 (95 % CI
0.8–2.37), and for the nine acute myeloid leukemias, the
SMR was 1.34 (95 % CI 0.66–2.54). In the US garment
workers study, SMRs were increased among workers
with C10 years exposure (SMR for myeloid leukemia
2.19, 95 % CI 0.95, 4.32) [69]4 and C20 years since first
exposure (SMR 1.91, 95 % CI 1.02, 3.27)5 [53].
No excesses were observed for all leukemia or for leu-
kemia subtypes among persons classified as exposed to
formaldehyde in the population-based case–control studies
[70, 71]. In the remaining occupational studies, risk esti-
mates for leukemia compared with the national or regional
populations were consistently close to the null value and
unstable due to small numbers.
The RR estimate was 5.79 (95 % CI 1.44, 23.25) for
leukemia among the combined exposure group of ‘‘formal-
dehyde-exposed and wood-related occupations’’ in the
American Cancer Society Cancer Prevention Study II;
however, this result was based on only two deaths. The RR
for those with formaldehyde exposure only was 0.96 (95 %
CI 0.54–1.71), based on 12 leukemia deaths [63].
Summary of lymphoma findings
The lymphoma results, including those for chronic lym-
phocytic leukemia (CLL) when reported separately, are
summarized in Table 3. With the exception of Hodgkin
lymphoma (HL), there were no overall excesses of the
lymphomas among exposed workers in the NCI producers
cohort; HL risk was associated with peak exposure, with
relative risk reaching 3.96 (95 % CI 1.31–12.02) only at
the highest exposure category (C4.0 ppm), based on 11
deaths. A similar, but weaker, trend was observed for HL
and average exposure (RR 2.48, 95 % CI 0.84–2.32) at the
highest category [39]. The only overall excess for any of
the lymphomas reported in the UK producers study was a
weak association for multiple myeloma (MM) in the sub-
group classified as mostly highly exposed workers (SMR
1.18, 95 % CI 0.48–2.44) [48]. Quantitative exposure–
response findings were not presented.
Results of the nested case–control study of embalmers
presented for all neoplasms of lymphoid origin, rather than
for non-Hodgkin lymphoma (NHL) or MM specifically, did
not suggest an association with any indices of formalde-
hyde exposure [54]. SMRs for lymphoma were less than
1.0 in the US garment workers study [53]. None of the
other occupational cohort studies reported a significantly
increased risk of NHL, HL, or MM (Table 3). Risk esti-
mates for NHL, HL, and MM in community-based studies
also suggested no association, with RR estimates ranging
between 0.5 and 1.3, although positive results were
reported in one NHL study from Connecticut [72]. Several
community-based studies provided results for NHL sub-
types, but there were no consistent associations [59–62].
Discussion
The main considerations pertinent to assessing epidemio-
logical evidence for a causal relation between formalde-
hyde exposure and the leukemias or other specific LHM are
consistency of findings across studies, evidence for expo-
sure–response associations, accuracy of exposure and
health outcome assessment, and minimal confounding and
bias. The extent to which exposure assessment in a given
study is valid, accurate, and, ideally, permits quantitative
dose–response estimation is a critical aspect of research
quality. Secondarily, epidemiologic findings suggestive of
an association should be interpreted in relation to available
evidence of mechanisms of pathogenesis.
The epidemiologic literature provides little or no evi-
dence indicating excess risks overall or exposure–response
4 95 % CI calculated from data presented in manuscript based on
method described by Rothman and Boice [69].
5 95 % CI calculated from data presented in manuscript based on
method described by Rothman and Boice [69].
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associations between formaldehyde and any of the LHM,
including leukemias, myeloid leukemias, and acute mye-
loid leukemias. In the majority of occupational cohort
studies, which we regard as most informative, specific
LHM risk estimates were consistent with the null value,
with few exceptions, where the excesses were generally
small (i.e., RR \ 1.5) and statistically imprecise.
The NCI producers cohort [39] and the nested case–
control analysis of the embalmers and funeral directors
group [54] found elevated risk estimates based on some
exposure metrics compared with an internal reference
group. However, the increased relative risk for myeloid
leukemia noted in an earlier follow-up of the NCI pro-
ducers cohort [47] had diminished in the most recent
update [39].
The strongest associations for myeloid leukemia
observed in this cohort were with peak exposures; whereas
cumulative exposure and average exposure intensity were
unrelated to risk. As described in the original publication
on the exposure assessment of the NCI producers study
[73], there was no uniform definition of peak exposure.
Instead, peak was defined on a job-specific basis as an
excursion (usually of short duration, e.g., \15 min) rela-
tive to the estimated average exposure for the job. More-
over, epidemiologic associations of a specific disease with
peak exposure can be difficult to interpret in the absence of
prior mechanistic support, such as the requirement for
acute above-threshold exposures. In general, established
human carcinogens show strong and consistent associations
between unbiased measures of cumulative exposure and
cancer risk, and cumulative exposure is the default dose
metric that is mostly used to assess cancer risk for etiologic
exposures. A re-analysis of the data from the previous
follow-up [47] corroborated the absence of associations
with cumulative exposure but also indicated no consistent
associations between myeloid leukemia and either duration
of time worked at the highest peak or time since highest
peak exposure [45]. Findings from similar re-analyses have
not been reported for the most recent follow-up. In the
other relatively strong occupational cohort study [48], there
was no association between formaldehyde exposure and
leukemia.
Among the other occupational studies, the US embalm-
ers study generated elevated odds ratios for some formal-
dehyde exposure metrics [54]. However, as noted by Cole
et al. [68], this study has notable limitations—including a
lack of overall excess leukemia risks (based on PMR
analysis), exposure assessment uncertainties, and a poorly
defined study base originating from a convenience sample
of death certificates obtained from previous proportionate
mortality studies. In the study of US garment workers [53],
the only support for an association with formaldehyde was
the observation of moderately elevated relative risks for
myeloid leukemia associated with long-term exposures and
longest follow-up that are very crude exposure metrics
correlated with older age. The results of the remaining
lower-quality studies are not supportive of an association
between formaldehyde exposure and leukemia risk.
Another recent review of the literature reached similar
conclusions for associations with the leukemias [74].
The pattern of epidemiological results for the lympho-
mas is inconsistent. In the NCI producers cohort, there
were some notably elevated relative risks (in the range of
2.5–4.0) observed for exposure categories of highest peak
for HL and MM [39, 47], yet null or at most very small
excesses for these diseases were reported in the other
studies of occupational formaldehyde exposure.
Consistency with toxicological and mechanistic
evidence
Studies of workers in China have evaluated a potential
association between exposure to formaldehyde and a
change in one or more blood parameters indicative of he-
matotoxicity [75–77]. Evidence suggestive of pancytopenia
and leukemia-specific chromosome changes was reported
from a study of Chinese formaldehyde melamine resin–
exposed workers [78]. However, the blood cell parameters
among exposed workers were largely within the normal
range for Chinese populations [79–82], and the chromo-
some findings were based on the progeny of circulating
stem cells from a small numbers of workers (n = 10–12)
after 14 days of culture. Overall, the available data do not
provide evidence of a clinically or biologically relevant
impact on blood cell parameters in humans following
exposure to formaldehyde.
Although mechanisms for the development of leukemia
or lymphoma following exposure to formaldehyde have
been hypothesized [75], they remain speculative. Notably,
proposed mechanisms rely heavily on the assumption that
formaldehyde can have direct effects on cells or tissues
beyond the portal of entry. One fundamental mechanistic
question critical to these hypotheses is whether exoge-
nously derived formaldehyde can enter the circulating
bloodstream and subsequently damage circulating precur-
sor cells or the bone marrow. Recent experimental
research, using extremely sensitive assays with the power
to detect as little as one exogenous DNA adduct in 10
billion deoxyguanosines, demonstrated identical endoge-
nously formed DNA formaldehyde adducts in all rat and
nonhuman primate non-portal-of-entry tissues, including
bone marrow. No exogenous adducts were detected in any
distant tissue [83–85]. These considerations call into
question the plausibility of causal links between formal-
dehyde and the LHM.
1762 Cancer Causes Control (2012) 23:1747–1766
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Conclusions and recommendations
Existing epidemiologic evidence does not provide con-
vincing support that formaldehyde causes any of the
LHMs, including myeloid leukemia. Findings among the
highest quality occupational cohort studies are largely null,
the positive findings are inconsistent in terms of strength
and specificity of association, and there are only isolated
instances of exposure–response relations. Epidemiologic
evidence from other formaldehyde-exposed occupational
cohorts is similarly inconsistent, is often based on small
numbers of events, and suffers from a greater likelihood of
exposure misclassification and other potential limitations
than the two large industrial cohort studies that we regard
as highest quality. Available community-based studies,
which generally have superior diagnostic classification but
poorer quality exposure assessment than in the occupa-
tional cohort mortality studies, provide no support for eti-
ologic associations of formaldehyde with any of the LHM.
Although we conclude that a causal connection between
formaldehyde exposure and LHM is not supported by
existing epidemiologic findings and that the evidence is
further weakened by the absence of established carcinogenic
mechanisms for the LHM, we nevertheless encourage fur-
ther epidemiologic research on this topic. We make this
recommendation with the caveat that, in order to be infor-
mative, further research should offer substantive improve-
ments over the existing body of studies, especially in terms
of application of modern diagnostic criteria for specific
LHM and individual level quantitative exposure assessment.
Well-defined occupational cohort studies should offer the
best opportunities to evaluate associations between form-
aldehyde exposure and LHM risks. Because formaldehyde
exposure is ubiquitous, accurately characterizing exposures
from the many possible sources, including combustion,
household furnishings, automobiles, and consumer prod-
ucts, is essentially impossible. Workplace exposures, on the
other hand, are typically substantially higher than exposures
from other environmental sources. Continued follow-up of
the established high-quality occupational cohorts would be
worthwhile, although the scientific yield may be limited
because exposure and health outcome misclassification
limitations can probably not be remedied. Re-analyses,
including sensitivity analysis, of existing datasets may add
insight into reported findings, as evidenced by previous re-
analyses of the NCI producers cohort data [45]. Specifically,
additional statistical analyses of risks of specific LHM in
relation to the various exposure metrics in the original NCI
producers study [73] are warranted.
A more attractive—but also more complicated and
expensive—option would be to enumerate and follow new
occupational cohorts exposed to formaldehyde. Professional
groups, such as anatomists, pathologists, funeral directors,
and embalmers, may be the most appropriate study popula-
tions because their exposures are frequent, generally remain
at relatively high intensity, and may not be confounded by
other potential exposures to leukemogens, such as benzene.
Another advantage to studying such professions is that they
are comprised of persons with comparable socioeconomic
status, a characteristic often associated with baseline rates of
LHM in the population.
In contrast, new cohort studies of industrial workers
would likely encounter problems related to vastly reduced
exposures in large workplaces during the past several
decades in many high-income countries, and the resulting
reduced capacity to test exposure-related associations rig-
orously. New occupational cohort studies in developing
economies may offer opportunities for further research.
Any new occupationally based studies should strive to
obtain incidence data with modern LHM classification, and
to incorporate valid, thorough exposure assessments for
formaldehyde and potential confounders. Cross-sectional
and, preferably, prospective investigations of biomarkers of
bone marrow toxicity relevant to carcinogenesis that have
adequate statistical power would also be worthwhile and
might be incorporated into cohort studies where feasible
(e.g., on subsets of workers).
In summary, we find insufficient epidemiologic evidence
to support a causal relation between formaldehyde exposure
and leukemia, including myeloid leukemia. We find no clear
evidence of an excess risk of leukemia or myeloid leukemia
in any large, well-conducted study. Furthermore, we find the
occasional positive associations between various exposure
metrics and leukemia or myeloid leukemia risk to be
inconsistent, and in some instances, contradictory to results
based on more conventional exposure characterization
approaches. We also find no epidemiologic basis on which to
conclude that formaldehyde causes any of the lymphomas.
Further weakening arguments for causal associations is the
absence of well-defined plausible models of pathogenesis.
Nevertheless, in view of the ubiquitous presence of formal-
dehyde in the population and experimental evidence indi-
cating high-dose carcinogenic potential, at least for portal-
of-entry sites, we recommend improved epidemiologic
research on potential risks for the LHM.
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